Skip to main content
Dryad

Research data on health facility-level factors that contribute to delayed diagnosis of cervical cancer

Data files

May 27, 2024 version files 229.24 KB

Abstract

In Kenya, cervical cancer is the 2nd commonly diagnosed type of cancer and the top cause of cancer-related deaths among women. Globally, over 50% of cervical cancer diagnoses are made late, with this proportion rising to 80% in developing countries. Poor Health systems can cause delays in diagnosis, thus, this study focused on determining the health facility-level factors that contribute to delayed diagnosis among cervical cancer patients at the Kenyatta National Hospital (KNH). An analytical cross-sectional mixed method study was adopted to collect data on hospital and referral experiences from 139 cervical cancer patients systematically sampled at KNH, using a semi-structured questionnaire. Associations between the stage at diagnosis and hospital and referral experiences were tested using a logistic regression model at 95% Confidence Interval. 86 (61.9%) were diagnosed at advanced stages III and IV. The potential predictors for delayed diagnosis were; More number of hospital referral times (p-value=0.000), Facing referral challenges (p-value=0.041), Longer time taken for diagnosis appointment (p-value=0.059), and Longer time taken for diagnostic results (p-value=0.007) in the bivariate analysis. More number of hospital referral times (p-value=0.001) and longer time taken for diagnostic results (p-value=0.025), were significantly associated with delayed diagnosis of cervical cancer in the multivariate logistic regression test model. Referral challenges included misdiagnosis, cost of diagnosis, and prolonged diagnosis appointments. The study concluded that the cause of delays in diagnosis for most patients is due to poor health and referral systems and inadequate medical personnel and diagnosis equipment. This study recommends improving referral systems and encouraging partnerships to decentralize diagnostic centers and equipment and train more expertise on cervical cancer.